Stay updated with breaking news from Immuni Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IRVINE, Calif.--(BUSINESS WIRE)--#ClinicalTrials--Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at the prestigious Innovative Therapies Days confere...
IRVINE, Calif., October 09, 2023--Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at the prestigious Innovative Therapies Days conference in Besançon, France. Innovative Therapies Days is a premier event in medical innovation, showcasing presentations from esteemed clinicians, scientists, and industry partners. This year, the confe
Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at
IRVINE, Calif.--(BUSINESS WIRE)--Aug 21, 2023--
IRVINE, Calif.--(BUSINESS WIRE)--#ClinicalTrials--Immunis, Inc., a private biotech and a leading innovator in cellular secretome therapies for age and disease-related immune decline, is honored to be selected as a finalist for the "Best Emerging Technology Company" by the Octane High Tech Awards (HTA). The HTA award...